Estrogen receptor β1 in diffuse large B-cell lymphoma growth and as a prognostic biomarker.

about

Estrogen receptor beta expression and prognosis of diffuse large B cell lymphoma.Survival associated alternative splicing events in diffuse large B-cell lymphoma

P2860

Q47651447-0E93569E-C972-4A97-860C-4CCD2A879688 Q58776059-401FF643-2413-41D6-8C97-8168E1036F4B

P2860

Estrogen receptor β1 in diffuse large B-cell lymphoma growth and as a prognostic biomarker.

Item

http://www.wikidata.org/entity/Q38847006

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Estrogen receptor β1 in diffus ...... and as a prognostic biomarker.

@en

type

Item

label

Estrogen receptor β1 in diffus ...... and as a prognostic biomarker.

@en

prefLabel

Estrogen receptor β1 in diffus ...... and as a prognostic biomarker.

@en

P1476

Estrogen receptor β1 in diffus ...... and as a prognostic biomarker.

@en

P2093

Gunilla Enblad

http://www.w3.org/2001/XMLSchema#string

Jiyu Guan

http://www.w3.org/2001/XMLSchema#string

Johan Linderoth

http://www.w3.org/2001/XMLSchema#string

Konstantin Yakimchuk

http://www.w3.org/2001/XMLSchema#string

Mattias Berglund

http://www.w3.org/2001/XMLSchema#string

Muhammad Sharif Hasni

http://www.w3.org/2001/XMLSchema#string

Rose Marie Amini

http://www.w3.org/2001/XMLSchema#string

Sam Okret

http://www.w3.org/2001/XMLSchema#string

P2860

Estrogen receptor (ER)-beta isoforms: a key to understanding ER-beta signaling

The role of gender in patients with diffuse large B cell lymphoma treated with rituximab-containing regimens: a meta-analysis

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001

Reproductive factors and non-Hodgkin lymphoma risk in the California Teachers Study.

Oestrogen receptors β1 and βcx have divergent roles in breast cancer survival and lymph node metastasis.

Prognostic role of gender in diffuse large B-cell lymphoma treated with rituximab containing regimens: a Fondazione Italiana Linfomi/Grupo de Estudos em Moléstias Onco-Hematológicas retrospective study.

ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer

Agonist activation of estrogen receptor beta (ERβ) sensitizes malignant pleural mesothelioma cells to cisplatin cytotoxicity.

P304

418-427

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10428194.2016.1193853

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27357538

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

Estrogen receptor β1 in diffuse large B-cell lymphoma growth and as a prognostic biomarker.

about

P2860

P2860

Estrogen receptor β1 in diffuse large B-cell lymphoma growth and as a prognostic biomarker.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921